Karishma
The role of hepatitis b virus biomarkers for diagnosing the progression of disease
Journal title : Yemen Journal of Medicine
Publisher : Mansa STM Publishers
Online ISSN : 2583-4614
Page Number : 485-486
Journal volume : 04
Journal issue : 02
40 Views Other
To the editor, Hepatitis B virus (HBV) infection remains a global public health concern, with over 296 million chronic carriers worldwide and an estimated 820,000 deaths annually due to HBV-related complications such as cirrhosis and hepatocellular carcinoma (HCC). [1] While serological markers like hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) have long been used in diagnosis and monitoring, emerging research has revealed the value of novel biomarkers in assessing disease progression, predicting treatment response, and guiding personalized care strategies.
Article DOI & Crossmark Data
DOI : https://doi.org/10.63475/yjm.v4i2.0161
Article Subject Details
Article Keywords Details
Article File
Full Text PDFMore Article by Karishma
The internal medicine residency program at hamad medical corporation (hmc) is accredited by the accreditation council for graduate medical education–international (acgme-i). upon c...
The city that never sleeps, a vibrant tapestry of dense neighborhoods and relentless energy, has long grappled with the pervasive challenge of air pollution. the very dynamism that...
Background: acute and chronic heart or kidney failure affect each other in cardiorenal syndromes (crs). in crs, hemodynamic and non-hemodynamic changes occur, causing acute or prog...
Dignity therapy (dt) is an evidence-based psychotherapeutic approach originally designed to alleviate emotional and existential distress in patients with terminal illnesses. while ...
More Hepatology Articles
Metapuf: a challenge response pair generator
Views: 3.5K
Frequency of statin-induced liver injury: a secondary analysis of previous hospital-based study
Views: 1.1K